To include your compound in the COVID-19 Resource Center, submit it here.

ECO-4601: Additional Phase I/II data

Additional data from the open-label, Canadian Phase I/II ECO-4601-101 trial in 26 advanced cancer patients showed that IV

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE